Literature DB >> 3614058

Symptoms improve after the eradication of gastric Campylobacter pyloridis.

T J Borody, J Carrick, S L Hazell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3614058     DOI： 10.5694/j.1326-5377.1987.tb120344.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  4 in total

1.  The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy.

Authors:  Francis Mégraud
Journal:  Therap Adv Gastroenterol       Date:  2012-03       Impact factor: 4.409

Review 2.  Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.

Authors:  Vasilios Papastergiou; Sotirios D Georgopoulos; Stylianos Karatapanis
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

3.  Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate.

Authors:  R J Loffeld; H V Potters; E Stobberingh; J A Flendrig; J P van Spreeuwel; J W Arends
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

4.  Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon.

Authors:  J Tarkkanen; T U Kosunen; E Saksela
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.